chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; Fatigue; has trouble breathing; chest still hurts; has a lung issue now; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0164, Expiry date: not reported), via an unspecified route of administration, in Arm Left on 23Apr2021 at 10:00 (age at vaccination: 65-year-old) as dose 2, single for COVID-19 immunization. Medical history included diabetes mellitus from an unknown date and unknown if ongoing diagnosed maybe 7-10 years ago, blood pressure high from an unknown date and unknown if ongoing diagnosed about 5 years ago, thyroid problems from an unknown date and unknown if ongoing diagnosed about 15 years ago, COVID-19 in Nov2020 for two weeks, and she went to Emergency Room four times for it. She says that it took her 3 months to recover from that. Previously, the patient previously received BNT162B2 (Lot number: ER8733), administered in Left arm on 25Mar2021 at 10:00 for COVID-19 immunization. The patient had to wait four weeks between to get those COVID-19 vaccines, but she had no other vaccines the days she got the doses or recently prior to that time. Not started any new medications. The patient reported that side effects happened after her second shot, she started having chills the following day (24Apr2021) and then fatigue. She says after the second shot felt like she was getting the virus all over again, and she went to the emergency room on an unknown date in Apr2021 and there they did COVID-19 virus test (rapid) and result was negative and they said she didn't have it and to follow up with her PCP. And also they performed blood work and CT scan and her doctor said she didn't know what all to do, just to check out organs, which were ok and her heart was ok, it was pumping, but the CT scan saw something in the lungs. She went to the doctors and they said unfortunately they don't know too much about the virus. She waited two months to go back thinking it would be getting better. She has trouble breathing, and can do a little work but then she is done for the rest of day, it tires her out. Her chest still hurts and has a lung issue now, and will see a pulmonary doctor on the 28th. It is not constant, it comes and goes, it is not getting any better. She thought maybe it would be after 3 months like when she had the virus, and she would be ok now, but it has been longer than 3 months. They have done no treatment yet, until she sees the doctor. The patient visited emergency room and physician office visit due to all the events. The outcome of all events was not recovered.
had prior anaphylactic reaction, seen at ED; This is a spontaneous report from a contactable physician (patient). A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 intramuscular, administered in arm left on 17Jun2021 12:00 (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. Patient age at vaccination was 52-year-old. The patient medical history included sulfa allergy. Patient was not pregnant. Historical vaccine included 1st dose of BNT162B2 on 27May2021 at 12:00 pm via intramuscular in left arm for COVID-19 Immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included levothyroxine sodium (SYNTHROID), duloxetine and fexofenadine hydrochloride (ALLEGRA), all taken for an unspecified indication, start and stop date were not reported.  The patient had prior anaphylactic reaction on 17Jun2021.  Event resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness (Immediate risk of death from Event). Therapeutic measures were taken as a result of event included epi x 2, steroids, Benadryl. Outcome of the event was not resolved.   Information on the lot/batch number has been requested.; Sender's Comments: A possible contributory effect of suspect BNT162B2  on reported events cannot be excluded  The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Information has been received from a nurse practitioner concerning an approximately 70 year old patient with cardiac failure who was vaccinated SQ with ZOSTAVAX (Oka/Merck) 0.65 ml (Lot # not reported). After getting ZOSTAVAX (Oka/Merck), the patient developed shingles six months to a year. The outcome of the patient's adverse events was not reported. It was reported that the patient's sought unspecified medical attention. Additional information has been requested.
Began with 102 fever for 3 days. About 24 hours after fever started I developed what looked like chickenpox blisters. Became very noticeable on day 3, saw my physician on day 4. Had blisters that eventually scabbed over after about 10 days
pt taken to hosp via ambulance p/apparent apneic episode; pt recvd vax on day of episode; pt got up from nap & became limp & turned blue while mom was changing diaper; pt pale but alert w/cyanosis; neuro exam intact;
The spontaneous report was received from a medical assistant refers to a patient of unknown age. On an unknown date, the patient was vaccinated with improperly stored doses of VARIVAX, lot # M000996, expiry date 07-JAN-2018. No adverse reactions were reported. Additional information has been requested.
Mild facial hives/rash noted roughly 10-15 minutes after getting vaccination.  Patient was referred to local ER.   Rash/hives self resolved per family several hours later.  Pt did not get any treatment for rash since family left ER prior to being seen.
This is a spontaneous report from a contactable consumer or other non health care professional. A 30-years-old male patient received BNT162B2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 09Mar2021 13:45 (Batch/Lot Number: EL3247) as SINGLE DOSE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took streptomycin and experienced drug hypersensitivity. The patient did not receive other vaccine in four weeks. The patient did not receive other medication in two weeks. On 10Mar2021 at 08:00 AM, the patient had experienced very sore arm the second day with pain in extremity, weakness, fatigue and mild fever. No treatment was received for the adverse events. The outcome of all events was not received. No follow-up attempts are possible; no further information is expected
This spontaneous report was received from a licensed practical nurse referring to a 20 year old patient with unknown gender. On 20-JUN-2016 the patient was inadvertently vaccinated with a pediatric dose of VAQTA (lot # M009377, expiration date: 17-JUN-2017; dose not reported) instead of the intended adult dose intramuscularly. No adverse effects were reported. Additional information has been requested.
Woke up the following morning shaking. As the day went on palpitations and chest pain started. It continued and shortness of breath developed. Since, many symptoms have appeared such as fatigue, dizziness, back pain, fluctuating blood pressure, adrenaline rushes, muscle weakness, tremors, vertigo, testicle pain, headaches and head pulsing. I am taking healthy vitamins and supplements to reduce body inflammation. I am still suffering to this day.
Very sore arm starting day of administration lasting for 2 days; resolved.  Headache and fatigue on day of vaccine starting about 4 hours after administration; resolved by the time I woke up the next morning.  Lymphadenopathy and tenderness in the armpit and supraclavicular nodes on the same side the vaccine was administered starting 1/1/2021, four days after the vaccine was administered and is not yet resolved, although the tenderness started to improve after 1 week on 1/7/2021.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 01-MAY-2016, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. In July 2016, the patient was treated for a blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Pt recvd 3 doses of Engerix-B & titer result was low; recvd booster dose of follow-up titer had dropped from initial titer;
Patient already on ventilator at time of my exam. Received report from Dr and nursing.  Seen at bedside with Dr.  Per ED:  41-year-old female with history of asthma presents to the emergency department with an asthma exacerbation.  Patient reports she began having cough and shortness of breath on Sunday.  She states she was seen at an outside hospital and given IV steroids and DuoNeb.  She states she was sent home with steroids, but never got these filled as she did not have a ride.  She reports her breathing got significantly worse last night.  She has given herself 6 DuoNebs throughout the night, with minimal improvement.  Patient denies vomiting or diarrhea.  She states she has had a cough.  Denies recent sick contacts.  Patient is in moderate respiratory distress.  She is able to speak in very short sentences/phrases only.   She was intubated in ED after bipap failed to get her pH improved or CO2 down. Chest Xray clear, now on vent no audible wheezing. Vitals fairly stable.  Reviewed imaging with nursing and NG in stomach. Fairly difficult to get sedated on versed and propofol.   PT IS CURRENTLY INPATIENT.
A month after vaccination, I had migraines, a hemiplegic migraine, left side paralysis in my face that radiated, and had speech issues and problems walking.
Patient received 2nd Pfizer vaccine and started having left leg weakness since February (per ER report on April 23,21). Report stated that pt had fell  frequently since that time.  Two falls on that exact day. The second resulted in  a hematoma on the back of his head. Since vaccine patient has to walk with crutches. Received CT and MRI showed negative results, but weakness and need to use crutches persists. Electronic note on 5.25.21 states:States pain sometimes makes him question his existence, but singing for church helps. Denies SI. Currently ambulates w/crutches and at risk for recurrent falls. Pt reporting increased depression 2/2 pain.
pt recv ax 30OCT96 woke up 31OCT96 w/red, pruritic hives & sore joints rt arm;took DPH;also c/o throat feels like is closing;31OCT had multiple red macular (no urticarial) rash on buttocks;face swollen;tingling of chin;dx allerg derma
I had no reaction to the vaccine. On 12/05/2022, I began not feeling well with a deep dry cough, low grade temperature and fatigue. On 12/10/2022, I tested positive for COVID-19 at an urgent care center with a PCR test. I was not a candidate for PAXLOVID. I was given a prescription for an inhaler, and I took acetaminophen for my symptoms. As of today, I still have a dry cough and loss of appetite.
BIVALENT VACCINE GIVEN TO PATIENT THAT HAD NOT RECEIVED ANY PRIMARY SERIES COVID VACCINE PRIOR (MONOVALENT OR BIVALENT)
Subsequent to receiving the first and second dosed of varicella virus vaccine live the pt became pregnant. The pt delivered an normal baby girl. This is in follow up to report(s) previously submitted on 05/16/2000. Information has been received through the Varivax pregancy registry from a RN concerning a 34 year old Native American female pt with an allergy to meperidine (Demerol) who on 12Nov97 and 16Dec97 was vaccinated with the first and second doses, respectively, of varicella virus vaccine live SC. Concomitant medication on 12Nov97 included multivitamins. Subsequently, the pt became pregnant (LMP:20Dec97, EDD:07Oct98). A cervical culture collected on 16Apr98 was negative for chlamydia and gonorrhea and a maternal serum alpha fetoprotein was within normal limits. An ultrasound performed on 14May98 was also within normal limits. At 11:03 hours on 15Oct98 the pt gave birth via spontaneous vaginal delivery to a normal Caucasian female baby (8lbs 0 oz) at 41 weeks gestation, with spontaneous respiration and no birth trauma reported. A pathological examination following delivery revealed a normal placenta. The pt experienced a slight fever of 99.6 degrees F and slight urinary discomfort post delivery. On 21Oct98, laboratory tests were performed for primary hypothyroidism, galactosemia, phenylketonuria, hemoglobin disorders, and congenital adrenal hyperplasia. All results were within normal limits. It was reported that on 16Oct98 the infant received one dose of hepatitis b vaccine IM in the left thigh. On 19Nov98 the child presented with drainage from the unbilicus with no signs of nitrate. On 10Dec98 the child presented with a lump on the outside corner of her left eye and the upper lid consistent with a small dermoid and no other signs of abnormality. Her growth and development were noted to be satisfactory. At this time the child was vaccinated with one dose each of poliovirus vaccine, hepatitis b vaccine, and haemophilus b conjugate vaccine. On 08Jan99 the child experienced congestion and a cough. No further information is available. This is an amended report. The pt's age was changed in the narrative from a 33 year old to a 34 year old. Vitamins were added to the other medication field. The reporter was changed. This is a corrected report, as amended.
Initially fatigue, headache, heavy limbs & watering puffy eyes.  Progressed to extreme facial swelling.  Used ice packs, Tylenol, Zyrtec. On 2/7/2021 went to  ER because eye swell increased.  They did not treat me.  Suggested I contact CDC & come back if worsens.  Suggested Benedryll & continue ice packs.  Woke up this morning (2/8) with continued swelling.
A report has been received from a Health Professional concerning a 2 year old, Male subject, who had been received FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on 03-Oct-2014. The patient experienced fever of 102, would not eat or drink and lethargic which started on 05-Oct-2014. The patient recovered from the event of fever of 102, would not eat or drink and lethargic on an unspecified date. The report was considered to be non-serious.
Vaccine recipient reported that after their 1st dose of Moderna, a week later they developed a site reaction on their left arm. Patient experienced contact dermatitis following vaccination. The area was hard, red, swollen and warm to touch. She also developed a small rash her on chest. On a follow up call on 2/2/2021 - Still has symptom; spreads if scratched and makes contact with another part of her body. Prescribed oral steroids.
first dose he had normal pain and trouble using his arm because of the pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 43 year-old male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "first dose he had normal pain and trouble using his arm because of the pain". The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200237614 same patient/drug, different dose, similar events
pt recvd vax 15AUG94 & 1 hr p/vax devel rash around mouth;  also devel urticaria; tx DPH
I was suffering from dizziness, nausea, frequent body and abdominal pain, and migraine for past 4-5 months but was not aware that this is because of the worst effect of this GARDASIL. I have not started any treatment yet. I already had 2 shots and final was due on 6th Mar 2010. I am also suffering from irregular monthly cycle after my miscarriage had on 8th Mar 2009. Still I am having same problem and taking Femilon as per Doctor's recommendation. I am not sure is this also because of this GARDASIL?
My second Shingrix Injection was on  December 31, 2020 at 8:00 PM.  Woke up at 6:30 on January 1, 2021 with a headache, which worsened throughout the day, to the point that I could not think straight.  Muscle aches, especially in the back of the neck.   Shaking and chills.    Fever was 102.8  at 6:00 pm on January 1, 2021.  Took two Tylenol, which brought the fever down and relieved the headache some.  Felt much better on January 2, but still had a bad headache, felt mentally "out of it"  and had chills.   I did not take my temperature again.    Today is January 5th and I still have a slight headache and feel "out of it" in the head.   I had the first  Shingrix  injection on October 8th or 9th.  I had the same symptoms but not quite as severe as with the second injection.
Patient received second dose of pfizer at facility unit on 4/27/2021. It was found that day a card in the patient's bag that she has received the moderna vaccine also from her PCP. Her 1st dose of Moderna was 3/17/1 1st dose pfizer 4/6/21, 2nd dose moderna 3/17/21 and 2nd dose pfizer 4/27/21. She is not exhibiting any adverse reactions at this time.
Patient presented to the emergency department with worsening cough, shortness of breath, diarrhea, his symptoms started around 1/5 , symptoms got worse. In ER patient was hypertensive with blood pressure 243/119, tachycardic with heart rate of 114, afebrile, saturating 95% on room air, point of care blood sugar was 525.  Patient did not take insulin when he started feeling sick.  Patient was treated with 2 L of nasal saline for lactic acidosis and hyperglycemia, patient was admitted for further evaluation and management.  Patient blood pressure and blood sugar improved, his diarrhea improved, patient continues to have cough, patient is on Robitussin and Tessalon Perles. Patient was receiving multivitamins vitamin-C, vitamin-D and zinc supplements for covid infection.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Jan2021 at 13:00 as dose 1, single (Lot number: EL9264), in right arm, on 19Feb2021 at 16:30 as dose 2, single (Lot number: Eng198), in left arm, on 14Aug2021 at 08:00 as dose 3 (booster), single (Lot number: Fd8448), in left arm and on 20May2022 at 17:00 as dose 4 (booster), single (Lot number: Fj4991) at the age of 61 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Sulfa allergy" (unspecified if ongoing); "Psoriasis" (unspecified if ongoing); "psoriatic arthritis" (unspecified if ongoing); "High cholesterol controlled by statins" (unspecified if ongoing). Concomitant medication(s) included: SUDAFED [XYLOMETAZOLINE HYDROCHLORIDE], start date: 24Jul2022, stop date: 02Aug2022; ALLEGRA; TALTZ; VITAMIN C [ASCORBIC ACID]; ROSUVASTATIN, start date: 01Feb2022, stop date: 24Jul2022. Past drug history included: Keflex, reaction(s): "Drug Allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical details include: Treatment was given as Paxlovid from 24Jul2022 to 28Jul2022. The patient reported, she was suck again with covid symptoms. Had bad cold symptoms, horrible sinus congestion, dry cough, achy, headaches, very tired and had fever again (100.6) tonight. She started feeling congested on July 31st and it was much worse.
Immediately the shot hurt.  The arm swelled up and was hot to the touch.  Headache started the following day and has not gone away since.  Entire body hurts and has muscle cramping and spasms that need to be controlled by muscle relaxers.  Physicians believe there is now an autoimmune disorder from the reaction to the tetanus vaccine and my tendons are now susceptible to tearing, my posterior tibial tendon is now torn and needs surgery.  I have had blood work, MRI's, Xrays.  I now have Lyme disease and several courses of antibiotics have not been successful in treating it.  I still test positive for multiple strains.  They are putting me in the infectious disease unit to do IV antibiotics now.  I have to take HCTZ for weird parts of my body that suddenly swell.
Shortly after vaccine received, left arm itching (severe), swelling, redness, pain c/o dizziness, hot to touch, pale, weak, no SOB or wheezing. Rec ER visit, mom refused. Pain sensation, radiation into shoulder and neck.
Scalp burning - severe hair loss by hand fulls - from 3/29 to present 5/20/21 continued hair loss Dermatologist visit 4/21/21  - prescribed Clobetasol Topical Solution  .05% -preformed biopsy - minor hair loss at time of visit   Some intestinal/stomach burning
20 spots on my back/new one on my wrist/and one on my leg; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (20 spots on my back/new one on my wrist/and one on my leg) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Covid in March and was hospitalized). Concurrent medical conditions included Heart rate irregular. Concomitant products included METOPROLOL and LISINOPRIL for Heart rate irregular.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced RASH MACULAR (20 spots on my back/new one on my wrist/and one on my leg). At the time of the report, RASH MACULAR (20 spots on my back/new one on my wrist/and one on my leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Prior to receiving vaccine patient had some spots on back, like insect bites, which continued to spread and patient thought of having bitten by a spider and now had a new one on wrist tonight which was just a bump right now, and one on leg.  Patient has not taken any treatment for the events.
An initial report was received from a health care professional on Jul 12 2005. A 19 year old female patient passed out after receiving Menactra, lot number UE2323AA intra muscularly in the right deltoid and Tubersol, lot number C2078AA intra derm ally on the left forearm on June 20 2005. She was sent to the hospital for evaluation but not admitted. She regained consciousness prior to hospital arrival, no treatment reported. EKG was normal and PPD was read as negative. The event was thought to be a vasovagal response. She has recovered.  Follow-up information was received on July 29, 2005. The vaccines injected were Menomune, lot number UE323AA (instead of Menactra; as previously reported.  The patient passed out 3 minutes after the vaccination. No further information  is available. The case is closed.